Non-small cell lung cancer (NSCLC) is a kind of cancer that forms in the tissues of the lung. It usually affects people with a history of smoking but can also develop in patients who've never smoked. Patients may benefit from a number of therapies, such as chemotherapy and radiation, depending on when NSCLC is detected.
At Mercy, we have a well-established lung cancer treatment program with above-average screening rates. By using low-dose CT scans, we're able to catch cancer at an earlier stage, which can lead to better treatment outcomes.
When it comes to lung cancer treatment, people choose Mercy for a variety of reasons, including:
Non-small cell lung cancer is the most common type of lung cancer, making up about 85% of cases. It grows more slowly than small cell lung cancer and includes subtypes like adenocarcinoma and squamous cell carcinoma. Mercy offers advanced testing options to patients to identify specific mutations for targeted treatment.
Non-small cell lung cancer symptoms often appear late, once the disease has taken hold. Common symptoms may include:
Mercy recommends annual low-dose CT scans for high-risk patients, such as smokers over the age of 50. These scans can detect non-small cell lung cancer earlier and improve your chances of survival.
Your lung health is our top priority. From diagnosis to recovery, we're here to guide you every step of the way. Stay connected with your care team by downloading our MyMercy app.
At Mercy, we offer comprehensive testing services to diagnose conditions and injuries, including:
At Mercy, we offer compassionate care for a variety of treatment services, including: